The Biotech Growth Trust (LON:BIOG) Stock Price Down 3.9% – Here’s Why

Shares of The Biotech Growth Trust PLC (LON:BIOGGet Free Report) fell 3.9% on Monday . The company traded as low as GBX 1,165 and last traded at GBX 1,175. 60,821 shares changed hands during trading, an increase of 44% from the average session volume of 42,177 shares. The stock had previously closed at GBX 1,222.50.

The Biotech Growth Trust Stock Down 3.9%

The company has a market capitalization of £249.05 million, a PE ratio of -82.17 and a beta of 0.50. The company’s fifty day moving average is GBX 1,193.98 and its 200-day moving average is GBX 998.15. The company has a debt-to-equity ratio of 11.02, a quick ratio of 0.00 and a current ratio of 0.59.

The Biotech Growth Trust (LON:BIOGGet Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported GBX (1) earnings per share for the quarter. The Biotech Growth Trust had a return on equity of 26.96% and a net margin of 95.33%.

Insider Transactions at The Biotech Growth Trust

In other The Biotech Growth Trust news, insider Julie Tankard purchased 369 shares of the business’s stock in a transaction on Wednesday, October 15th. The stock was acquired at an average price of GBX 1,072 per share, for a total transaction of £3,955.68. Insiders own 2.66% of the company’s stock.

About The Biotech Growth Trust

(Get Free Report)

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).

Further Reading

Receive News & Ratings for The Biotech Growth Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Biotech Growth Trust and related companies with MarketBeat.com's FREE daily email newsletter.